Pitting COVID-19 drug candidates against the virus in cell cultures doesn't accurately predict how effective they'll be in the human respiratory tract. Now more accurate models of the human lung airway are uncovering new treatment candidates. They include the antimalarial drug amodiaquine, which reduced viral load in animal models of the virus by 70%.